Skip to main content
. 2017 Jun;9(6):1598–1606. doi: 10.21037/jtd.2017.05.78

Table 1. Patient characteristics.

Study variable Drainage system, n (%) P value
Atrium (Analog) Thopaz (Digital)
Sample size N=50 N=53
Gender 0.488
   Male 27 (51.9) 25 (48.1)
   Female 23 (45.1) 28 (54.9)
Age, mean, SD 64.8, 10.6 68.5, 10.3 0.077
Previous cancer 0.653
   Yes 22 (51.2) 21 (48.8)
   No 28 (46.7) 32 (53.3)
Cardiac diseases (MI or arrhythmia) 0.850
   Yes 15 (50.0) 15 (50.0)
   No 35 (47.9) 38 (52.1)
COPD 0.480
   Yes 12 (42.9) 16 (57.1)
   No 38 (50.7) 37 (49.3)
Obstructive sleep apnea 0.111
   Yes 3 (100.0) 0
   No 47 (47.0) 53 (53.0)
Hypercholesterol 0.283
   Yes 8 (38.1) 13 (61.9)
   No 42 (51.2) 40 (48.8)
Diabetes 0.474
   Yes 6 (40.0) 9 (60.0)
   No 44 (50.0) 44 (50.0)
VTE 0.243
   Yes 0 3 (100.0)
   No 50 (50.0) 50 (50.0)
Current NSAID use 1.00
   Yes 2 (40.0) 3 (60.0)
   No 48 (49.0) 50 (51.0)
Smoking 0.195
   Current 14 (53.8) 12 (46.2)
   Quit less than 1 year ago 8 (66.7) 4 (33.3)
   Quit more than 1 year ago 14 (35.9) 25 (64.1)
   Never 14 (53.8) 12 (46.2)
Smoking pack years 0.388
   0 14 (53.8) 12 (46.2)
   <10 1 (20.0) 4 (80.0)
   10–20 5 (33.3) 10 (66.7)
   20–40 15 (48.4) 16 (51.6)
   >40 15 (57.7) 11 (42.3)
FEV1 (%) 0.793
   >80 37 (49.3) 38 (50.7)
   <80 13 (46.4) 15 (53.6)
DLCO (%) 0.399
   >80 16 (55.2) 13 (44.8)
   <80 34 (45.9) 40 (54.1)
BMI 0.407
   <18.5 0 2 (100)
   18.5–25 15 (50.0) 15 (50.0)
   25–30 21 (55.3) 17 (44.7)
   >30 14 (42.4) 19 (57.6)
Surgeon identification 0.853
   1 20 (48.8) 21 (51.2)
   2 12 (44.4) 15 (55.6)
   3 18 (51.4) 17 (48.6)
Procedure 0.664
   Lobectomy 32 (49.2) 33 (50.8)
   Bilobectomy 4 (80.0) 1 (20.0)
   Segmentectomy 6 (42.9) 8 (57.1)
   Single wedge 4 (40.0) 6 (60.0)
   Multiple wedge 4 (44.4) 5 (55.6)
Procedure type 0.363
   Open 29 (52.7) 26 (47.3)
   VATS 21 (43.8) 27 (56.2)
Resection type 0.394
   Lobe 36 (51.4) 34 (48.6)
   Sublobar 14 (42.4) 19 (57.6)
Side of resection 0.286
   Left 26 (54.2) 22 (45.8)
   Right 24 (43.6) 31 (56.4)

NSAID, non-steroidal anti-inflammatory drug; VATS, video-assisted thoracoscopic surgery.